HEC122505MsOH
HEC122505-P-01/CRC-C2017
Phase 1 small_molecule completed
Quick answer
HEC122505MsOH for Parkinson Disease is a Phase 1 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Parkinson Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed